Aytu BioPharma, Inc.

AYTU · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$2-$20$4$1
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0$2-$10$3
Other Non-Cash-$3$20-$2-$2
Operating Cash Flow-$1$3-$6$3
Investing Activities
PP&E Inv.$0-$3-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$3-$0$0
Financing Activities
Debt Repay.$2-$2$6-$1
Stock Issued$0$15$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0-$1-$2
Financing Cash Flow$2$13$4-$3
Forex Effect$0$0$0$0
Net Chg. in Cash$2$13-$2$0
Supplemental Information
Beg. Cash$31$18$20$20
End Cash$33$31$18$20
Free Cash Flow-$1$3-$7$3
Aytu BioPharma, Inc. (AYTU) Financial Statements & Key Stats | AlphaPilot